These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 22405901)

  • 1. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.
    Yang FY; Teng MC; Lu M; Liang HF; Lee YR; Yen CC; Liang ML; Wong TT
    Int J Nanomedicine; 2012; 7():965-74. PubMed ID: 22393293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.
    Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT
    PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
    Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
    J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
    Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
    Lin YL; Wu MT; Yang FY
    J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
    Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of glioblastoma by targeted liposomal platinum compounds with focused ultrasound.
    Yang FY; Horng SC
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():6289-92. PubMed ID: 24111178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
    Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
    Arai T; Benny O; Joki T; Menon LG; Machluf M; Abe T; Carroll RS; Black PM
    Anticancer Res; 2010 Apr; 30(4):1057-64. PubMed ID: 20530409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
    Zhu F; Jiang Y; Luo F; Li P
    J Drug Target; 2015 May; 23(4):323-34. PubMed ID: 25609362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.
    Madhankumar AB; Slagle-Webb B; Mintz A; Sheehan JM; Connor JR
    Mol Cancer Ther; 2006 Dec; 5(12):3162-9. PubMed ID: 17172420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy.
    Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin VP; Ahmed M
    PLoS One; 2014; 9(8):e102727. PubMed ID: 25133740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
    VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
    J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.
    Hijnen N; Kneepkens E; de Smet M; Langereis S; Heijman E; Grüll H
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4802-E4811. PubMed ID: 28566498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model.
    Madhankumar AB; Slagle-Webb B; Wang X; Yang QX; Antonetti DA; Miller PA; Sheehan JM; Connor JR
    Mol Cancer Ther; 2009 Mar; 8(3):648-54. PubMed ID: 19276162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.